AI-generated summary
The authors studied 26 patients with meibomian gland dysfunction who received intense regulated pulse light treatment over three sessions in one eye. They report improved Schirmer and tear break-up times, better symptom questionnaire scores, and no adverse ocular effects, while Oxford grading and other gland measures did not change significantly. The study was uncontrolled and small.
- Participants
- 26
- Who or what was studied
- 26 patients with meibomian gland dysfunction treated in one eye at a Turkish ophthalmology department
- Limits stated in the abstract
- The abstract describes a small sample and does not indicate a control group, so the findings cannot be attributed to the treatment alone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.